Modulation of epitranscriptomic code for cancer therapy - a feasibility study

• Unité de recherche: INNOSUISSE
• Numéro de projet: 33520.1 IP-LS
• Titre du projet anglais: Modulation of epitranscriptomic code for cancer therapy - a feasibility study

Description succincte (Allemand)

Modulation of epitranscriptomic code for cancer therapy - a feasibility study

Description succincte (Anglais)

Modulation of epitranscriptomic code for cancer therapy - a feasibility study

Résumé des résultats (Abstract) (Allemand)

In this feasibility study we will provide the in vitro proof of concept for therapeutic value of targeting epitranscriptomics (RNA epigenetics) modification machinery for cancer therapy.